Synaptogenix Inc. (SNPX)
3.53
0.26 (7.95%)
At close: Jan 14, 2025, 9:00 PM
Cashflow (Annual)
Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 |
| Net Income | -6.04M | -5.57M | -12.61M | -12.70M | -15.13M | -11.02M |
| Depreciation & Amortization | 6.35K | 5.71K | 4.97K | 4.87K | 4.38K | 3.00K |
| Stock-Based Compensation | 1.01M | 3.74M | 3.28M | 1.70M | 4.18M | n/a |
| Other Working Capital | 573.60K | 21.35K | -10.24K | -153.44K | 116.69K | -552.64K |
| Other Non-Cash Items | -508.40K | -8.77M | 27.16K | 120.00K | 352.75K | 564.06K |
| Deferred Income Tax | n/a | n/a | 560.03K | 2.08M | 1.08M | n/a |
| Change in Working Capital | 358.02K | -614.95K | 25.93K | 693.81K | -2.37M | 1.11M |
| Operating Cash Flow | -5.17M | -11.21M | -8.71M | -8.10M | -11.89M | -7.70M |
| Capital Expenditures | -2.71K | -7.41K | -3.20K | -5.41K | -5.21K | -3.19K |
| Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a |
| Purchase of Investments | -2.00M | n/a | n/a | n/a | n/a | n/a |
| Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Investing Acitivies | n/a | n/a | n/a | n/a | n/a | n/a |
| Investing Cash Flow | -2.00M | -7.41K | -3.20K | -5.41K | -5.21K | -3.19K |
| Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a |
| Common Stock Repurchased | -1.00M | n/a | n/a | n/a | n/a | n/a |
| Dividend Paid | -641.07K | -115.89K | n/a | -20.00M | n/a | n/a |
| Other Financial Acitivies | -1.00M | 669.04K | 13.35M | n/a | 419.84K | n/a |
| Financial Cash Flow | -1.64M | 14.48M | 37.13M | -3.48M | 419.84K | 20.44M |
| Net Cash Flow | -8.82M | 3.26M | 28.42M | -11.59M | -11.47M | 12.74M |
| Free Cash Flow | -5.18M | -11.22M | -8.71M | -8.11M | -11.89M | -7.70M |